HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Hutchinson's triad — Clinical Guidelines

Overview

Hutchinson's triad, also known as follicular occlusion triad, comprises hidradenitis suppurativa (HS), acne conglobata (AC), and dissecting cellulitis of the scalp (DCS). It is characterized by chronic inflammatory follicular disorders affecting multiple areas of the body. 4

Diagnosis

Clinical Presentation: Presence of HS, AC, and DCS.

Histopathology: Examination of skin biopsies may show characteristic features such as hyperkeratosis, follicular plugging, and inflammatory infiltrates.

Genetic Testing: Consider in cases with atypical presentations or familial clustering; novel connexin 26 mutations may be implicated 3.

Differential Diagnosis: Rule out other inflammatory skin conditions and malignancies, especially in recalcitrant cases 4.

Management

First-Line Treatments:

- Topical Agents: Antibiotics, retinoids (e.g., 13-cis-retinoic acid). - Systemic Antibiotics: For moderate to severe inflammatory activity.

Adjunctive Treatments:

- Corticosteroids: Intralesional or systemic for severe inflammation. - Biologics: TNF-α inhibitors (e.g., adalimumab) for refractory cases 4.

Surgical Interventions: Excision of abscesses, sinus tracts, and in severe cases, definitive surgical management 4.

Special Populations

Pediatrics: Childhood obesity is associated with an elevated risk of early-onset FOT, including HS, AC, and DCS 1.

Comorbidities: Consider occult malignancies in patients with recalcitrant acne conglobata, especially after prolonged use of retinoids 4.

Key Recommendations

Monitor and manage childhood obesity to potentially reduce the risk of early-onset follicular occlusion triad 1 (Evidence: Moderate).

Consider genetic testing for connexin 26 mutations in patients with atypical presentations or familial clustering of follicular occlusion triad 3 (Evidence: Weak).

Evaluate for underlying malignancies in patients with recalcitrant acne conglobata, particularly in areas unresponsive to medical management 4 (Evidence: Moderate).

References

1 Kim SR, Koh SJ, Park H. Association of childhood obesity or weight change with early-onset follicular occlusion triad in children. The British journal of dermatology 2025. link 2 Liu JC, Liu XG, Xu C, Zhao HF, Jiang XZ. Scrotal elephantiasis associated with follicular occlusion triad: A case report and literature review. Medicine 2019. link 3 Montgomery JR, White TW, Martin BL, Turner ML, Holland SM. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. Journal of the American Academy of Dermatology 2004. link 4 Chicarilli ZN. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Annals of plastic surgery 1987. link

Hutchinson's triad